https://doi.org/10.4081/monaldi.2021.1749
Post COVID-19 tuberculosis: An emerging threat of pandemic
Submitted: December 24, 2020
Accepted: January 26, 2021
Published: March 31, 2021
Accepted: January 26, 2021
Abstract Views: 5248
PDF: 1077
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has hit the world hard. Millions of people have died due to the infection and several have suffered with what are now known as post COVID-19 squeal. Among these squeals one is immunosuppression which leaves patients prone to severe opportunistic infection. We here report a case of young female who was infected by COVID-19 and later developed cavitary pneumonia which upon investigation turned out to be due to mycobacterium tuberculosis. Through this report we aim to highlight the importance of high index of suspicion for infection like Mycobacterium tuberculosis after COVID-19 infection which developed in a healthy immunocompetent patient.
Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020;8:19.
DOI: https://doi.org/10.1016/S2213-2600(19)30418-7
Bartoletti M, Pascale R, Cricca M, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis 2020:ciaa1065.
Choy CY, Wong CS. It's not all about COVID‐19: Pneumocystis pneumonia in the era of a respiratory outbreak. J Int AIDS Soc 2020;23:e25533.
DOI: https://doi.org/10.1002/jia2.25533
Tadolini M, Codecasa LR, García-García JM, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020;56:2001398.
DOI: https://doi.org/10.1183/13993003.01398-2020
Gupta N, Ish P, Gupta A, et al. A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis. Eur Respir J 2020;56:2003408.
DOI: https://doi.org/10.1183/13993003.03408-2020
Rakesh PS, et al. Mortality among individuals with TB-COVID-19 coinfection: initial observations from Kerala, India. Int J Tuberc Lung Dis 2021; in press
Motta I, Centis R, D’Ambrosio L, et al. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology 2020;26:233-40.
DOI: https://doi.org/10.1016/j.pulmoe.2020.05.002
Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med 2013;2013:828939.
DOI: https://doi.org/10.1155/2013/828939
Zumla A, Marais BJ, McHugh TD, et al. COVID-19 and tuberculosis—threats and opportunities. Int J Tubercul Lung Dis 2020;24:757-60.
DOI: https://doi.org/10.5588/ijtld.20.0387
Alagna R, Besozzi G, Codecasa LR, et al. Celebrating world tuberculosis day at the time of COVID-19. Eur Respir J 2020;55:2000650.
DOI: https://doi.org/10.1183/13993003.00650-2020
Dara M, Sotgiu G, Reichler MR, et al. New diseases and old threats: lessons from tuberculosis for the COVID-19 response. Int J Tuberc Lung Dis 2020;24:544-5.
DOI: https://doi.org/10.5588/ijtld.20.0151
Migliori GB, Thong PM, Akkerman O, et al. Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020. Emerg Infect Dis 2020;26:2709.
DOI: https://doi.org/10.3201/eid2611.203163
Supporting Agencies
noneHow to Cite
Zahid, Aqusa, Nousheen Iqbal, Sarosh Moeen, and Muhammad Irfan. 2021. “Post COVID-19 Tuberculosis: An Emerging Threat of Pandemic”. Monaldi Archives for Chest Disease 91 (3). https://doi.org/10.4081/monaldi.2021.1749.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- S.M. Mirsaeidi, P. Tabarsi, A. Mardanloo, G. Ebrahimi, M. Amiri, P. Farnia, M. Sheikhleslami, V. Bakayev, F. Mohammadi, S.D. Mansouri, M.R. Masjedi, A.A. Velayati, Pulmonary Mycobacterium Simiae infection and HTLV1 infection: an incidental co-infection or a predisposing factor? , Monaldi Archives for Chest Disease: Vol. 65 No. 2 (2006): Pulmonary series
- S.M. Mirsaeidi, P. Tabarsi, M.O. Edrissian, M. Amiri, P. Farnia, S.D. Mansouri, M.R. Masjedi, A.A. Velayati, Primary multi-drug resistant tuberculosis presented as lymphadenitis in a patient without HIV infection , Monaldi Archives for Chest Disease: Vol. 61 No. 4 (2004): Pulmonary series
- G.L. Casoni, C. Gurioli, P.N. Chhajed, M. Chilosi, M. Zompatori, D. Olivieri, V. Poletti, The value of transbronchial lung biopsy using jumbo forceps via rigid bronchoscope in diffuse lung disease , Monaldi Archives for Chest Disease: Vol. 69 No. 2 (2008): Pulmonary series
- A.A. Velayati, P. Farnia, M.R. Boloorsaze, M.F. Sheikholslami, S. Khalilzadeh, S.S. Hakeeme, M.R. Masjedi, Mycobacterium Bovis infection in children in the same family: transmission through inhalation , Monaldi Archives for Chest Disease: Vol. 67 No. 3 (2007): Pulmonary series
- Neeta Singla, Amitesh Gupta, U.K. Khalid, Ravindra Kumar Dewan, Rupak Singla, Clinical profile, risk factors, disease severity, and outcome for COVID-19 disease in patients with tuberculosis on treatment under the National Tuberculosis Elimination Program: a cohort of 1400 patients , Monaldi Archives for Chest Disease: Early Access
- Ali Asghar Hemmati, Soheila Alboghobeish, Akram Ahangarpour, Chronic exposure to high fat diet exacerbates arsenic-induced lung damages in male mice: Possible role for oxidative stress , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- Amanda R. Jimenez, Arielle Shaeffer Weiss, Anthony C. Campagna, Use of pulmonary function test demographic data to identify high-risk patients for lung cancer screening , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- T. Kontakiotis, N. Manolakoglou, F. Zoglopitis, D. Iakovidis, L. Sacas, A. Papagiannis, A. Mandrali, D. Papakosta, P. Argyropoulou, D. Bouros, Epidemiologic trends in lung cancer over two decades in Northern Greece: an analysis of bronchoscopic data , Monaldi Archives for Chest Disease: Vol. 71 No. 4 (2009): Pulmonary series
- M. Justine, F. Tahirah, V. Mohan, Health-related quality of life, lung function and dyspnea rating in COPD patients , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series
- A. Kaya, Z. Topu, S. Fitoz, N. Numanoglu, Pulmonary tuberculosis with multifocal skeletal involvement , Monaldi Archives for Chest Disease: Vol. 61 No. 2 (2004): Pulmonary series
You may also start an advanced similarity search for this article.
